Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved

Molecular and Cellular Endocrinology

Volumn 341, Issue 1-2, 2011, Pages 9-17

  Møller, Cathrine Laustrup ^a,b   Raun, Kirsten ^a   Jacobsen, Marianne Lambert ^a   Pedersen, Thomas Åskov ^a   Holst, Birgitte ^b   Conde Frieboes, Kilian W ^a   Wulff, Birgitte Schjellerup ^a  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

3T3 L1 cells; Adenosine 5 monophosphate activated protein kinase (AMPK); Adipocytes; CAMP; Extracellular signal regulated kinase (ERK); Isolated mouse epididymal adipocytes; Jun amino terminal kinase (JNK); Lipolysis; Melanocortin receptor 1 5; NEFA; Protein kinase B (PKB); Real time PCR; Signalling; Western blotting

Indexed keywords

ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; CORTICOTROPIN; CYCLIC AMP; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOTAN II; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PROOPIOMELANOCORTIN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN 3T3; CONTROLLED STUDY; EPIDIDYMIS FAT; GENE EXPRESSION; IC 50; LIPOLYSIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BINDING, COMPETITIVE; CYCLIC AMP; EPIDIDYMIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; HORMONES; LIPOLYSIS; MALE; MAP KINASE SIGNALING SYSTEM; MELANOCORTINS; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, MELANOCORTIN, TYPE 2; RECEPTORS, MELANOCORTIN;

EID: 79960587373     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.03.010     Document Type: Article

References (55)

1. Abdel-Malek Z., Scott M.C., Suzuki I., Tada A., Im S., Lamoreux L., Ito S., Barsh G., Hearing V.J. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res. 2000, 13(Suppl. 8):156-162.
2. Ahmed K., Tunaru S., Offermanns S. GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol. Sci. 2009, 30(November (11)):557-562.
3. An J.J., Rhee Y., Kim S.H., Kim D.M., Han D.H., Hwang J.H., Jin Y.J., Cha B.S., Baik J.H., Lee W.T., Lim S.K. Peripheral effect of alpha-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. J. Biol. Chem. 2007, 282:2862-2870.
4. Azzara A.V., Sokolnicki J.P., Schwartz G.J. Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition. Physiol. Behav. 2002, 77:411-416.
5. Barrett P., MacDonald A., Helliwell R., Davidson G., Morgan P. Cloning and expression of a new member of the melanocyte-stimulating hormone receptor family. J. Mol. Endocrinol. 1994, 12(2):203-213.
6. Baumann J.B., Eberle A.N., Christen E., Ruch W., Girard J. Steroidogenic activity of highly potent melanotropic peptides in the adrenal cortex of the rat. Acta Endocrinol. (Copenh.) 1986, 113(3):396-402.
7. Bednarek M.A., MacNeil T., Tang R., Fong T.M., Angeles C.M., Maroto M., Teran A. Potent and selective peptide agonists of alpha-melanocyte stimulating hormone (alphaMSH) action at human melanocortin receptor 5; their synthesis and biological evaluation in vitro. Chem. Biol. Drug Des. 2007, 69:350-355.
8. Boston B.A. The role of melanocortins in adipocyte function. Ann. N.Y. Acad. Sci. 1999, 885:75-84.
9. Boston B.A., Cone R.D. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 1996, 137:2043-2050.
10. Bradley R.L., Mansfield J.P., Maratos-Flier E. Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes. Obes. Res. 2005, 13:653-661.
11. Brito M.N., Brito N.A., Baro D.J., Song C.K., Bartness T.J. Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 2007, 148:5339-5347.
12. Buch T.R., Heling D., Damm E., Gudermann T., Breit A. Pertussis toxin-sensitive signaling of melanocortin-4 receptors in hypothalamic GT1-7 cells defines agouti-related protein as a biased agonist. J. Biol. Chem. 2009, 284:26411-26420.
13. Chagnon Y.C., Chen W.J., Perusse L., Chagnon M., Nadeau A., Wilkison W.O., Bouchard C. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol. Med. 1997, 3:663-673.
14. Chan L.F., Webb T.R., Chung T.T., Meimaridou E., Cooray S.N., Guasti L., Chapple J.P., Egertova M., Elphick M.R., Cheetham M.E., Metherell L.A., Clark A.J. MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6146-6151.
15. Cheung C.C., Clifton D.K., Steiner R.A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997, 138:4489-4492.
16. Cho K.J., Shim J.H., Cho M.C., Choe Y.K., Hong J.T., Moon D.C., Kim J.W., Yoon D.Y. Signaling pathways implicated in alpha-melanocyte stimulating hormone-induced lipolysis in 3T3-L1 adipocytes. J. Cell. Biochem. 2005, 96:869-878.
17. Cone R.D. The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 1999, 10:211-216.
18. Daniels D., Patten C.S., Roth J.D., Yee D.K., Fluharty S.J. Melanocortin receptor signaling through mitogen-activated protein kinase in vitro and in rat hypothalamus. Brain Res. 2003, 986:1-11.
19. Dicker A., Astrom G., Wahlen K., Hoffstedt J., Naslund E., Wiren M., Ryden M., Arner P., van Harmelen V. Primary differences in lipolysis between human omental and subcutaneous adipose tissue observed using in vitro differentiated adipocytes. Horm. Metab. Res. 2009, 41(5):350-355.
20. Doghman M., Soltani Y., Rebuffet V., Naville D., Begeot M. Role of Agouti-related protein in adrenal steroidogenesis. Mol. Cell. Endocrinol. 2007, 265-266:108-112.
21. Fan W., Dinulescu D.M., Butler A.A., Zhou J., Marks D.L., Cone R.D. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000, 141:3072-3079.
22. Farooqi I.S., Keogh J.M., Yeo G.S., Lank E.J., Cheetham T., O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 2003, 348:1085-1095.
23. Greenfield J.R., Miller J.W., Keogh J.M., Henning E., Satterwhite J.H., Cameron G.S., Astruc B., Mayer J.P., Brage S., See T.C., Lomas D.J., O'Rahilly S., Farooqi I.S. Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 2009, 360:44-52.
24. Grieco P., Han G., Weinberg D., Van der Ploeg L.H., Hruby V.J. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. Biochem. Biophys. Res. Commun. 2002, 292:1075-1080.
25. Haskell-Luevano C., Nikiforovich G., Sharma S.D., Yang Y.K., Dickinson C., Hruby V.J., Gantz I. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. J. Med. Chem. 1997, 40(11):1738-1748.
26. Hoch M., Eberle A.N., Wagner U., Bussmann C., Peters T., Peterli R. Expression and localization of melanocortin-1 receptor in human adipose tissues of severely obese patients. Obesity (Silver Spring) 2007, 15:40-49.
27. Hruby V.J., Lu D., Sharma S.D., Castrucci A.L., Kesterson R.A., al-Obeidi F.A., Hadley M.E., Cone R.D. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, d-Phe7 Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 1995, 38(18):3454-3461.
28. Huo L., Gamber K., Greeley S., Silva J., Huntoon N., Leng X.H., Bjorbaek C. Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell. Metab. 2009, 9:537-547.
29. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
30. Konda Y., Gantz I., DelValle J., Shimoto Y., Miwa H., Yamada T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 1994, 269:13162-13166.
31. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 1998, 19:155-157.
32. Marks D.L., Butler A.A., Cone R.D. Melanocortin pathway: animal models of obesity and disease. Ann. Endocrinol. (Paris) 2002, 63:121-124.
33. Marks D.L., Hruby V., Brookhart G., Cone R.D. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 2006, 27:259-264.
34. Mountjoy K.G. Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochem. J. 2010, 428(3):305-324.
35. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 1994, 8:1298-1308.
36. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone RD The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257(5074):1248-1251.
37. Mountjoy K.G., Wild J.M. Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems. Brain Res. Dev. Brain Res. 1998, 107:309-314.
38. Robidoux J., Kumar N., Daniel K.W., Moukdar F., Cyr M., Medvedev A.V., Collins S. Maximal beta3-adrenergic regulation of lipolysis involves Src and epidermal growth factor receptor-dependent ERK1/2 activation. J. Biol. Chem. 2006, 281:37794-37802.
39. Rodrigues A.R., Pignatelli D., Almeida H., Gouveia A.M. Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism. Mol. Cell. Endocrinol. 2009, 303:74-81.
40. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.L., Simerly R.B., Cone R.D. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8856-8860.
41. Schioth H.B., Muceniece R., Larsson M., Mutulis F., Szardenings M., Prusis P., Lindeberg G., Wikberg J.E. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur. J. Pharmacol. 1997, 319:369-373.
42. Sebag J.A., Hinkle P.M. Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling. J. Biol. Chem. 2009, 284:610-618.
43. Shishioh-Ikejima N., Ogawa T., Yamaguti K., Watanabe Y., Kuratsune H., Kiyama H. The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients. BMC Neurol. 2010, 10:73.
44. Smith S.R., Gawronska-Kozak B., Janderova L., Nguyen T., Murrell A., Stephens J.M., Mynatt R.L. Agouti expression in human adipose tissue: functional consequences and increased expression in type 2 diabetes. Diabetes 2003, 52:2914-2922.
45. Song C.K., Jackson R.M., Harris R.B., Richard D., Bartness T.J. Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue. Am. J. Physiol Regul. Integr. Comp. Physiol. 2005, 289:R1467-R1476.
46. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
47. Spirovski M.Z., Kovacev V.P., Spasovska M., Chernick S.S. Effect of ACTH on lipolysis in adipose tissue of normal and adrenalectomized rats in vivo. Am. J. Physiol. 1975, 228:382-385.
48. Tschop M., Heiman M.L. Rodent obesity models: an overview. Exp. Clin. Endocrinol. Diabetes 2001, 109:307-319.
49. van der Kraan M., Adan R.A., Entwistle M.L., Gispen W.H., Burbach J.P., Tatro J.B. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 1998, 139:2348-2355.
50. van Harmelen V., Dicker A., Ryden M., Hauner H., Lonnqvist F., Naslund E., Arner P. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 2002, 51(7):2029-2036.
51. Vassaux G., Gaillard D., Darimont C., Ailhaud G., Negrel R. Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: physiological implications. Endocrinology 1992, 131(5):2393-2398.
52. Wallingford N., Perroud B., Gao Q., Coppola A., Gyengesi E., Liu Z.W., Gao X.B., Diament A., Haus K.A., Shariat-Madar Z., Mahdi F., Wardlaw S.L., Schmaier A.H., Warden C.H., Diano S. Prolylcarboxypeptidase regulates food intake by inactivating alpha-MSH in rodents. J. Clin. Invest. 2009, 119(8):2291-2303.
53. Wikberg J.E., Muceniece R., Mandrika I., Prusis P., Lindblom J., Post C., Skottner A. New aspects on the melanocortins and their receptors. Pharmacol. Res. 2000, 42:393-420.
54. Yaswen L., Diehl N., Brennan M.B., Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 1999, 5:1066-1070.
55. Zemel M.B., Shi H. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity. Nutr. Rev. 2000, 58(6):177-180.